GILD
Gilead Sciences Inc.
Latest News for GILD
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Gilead Sciences (GILD), Viatris (VTRS) and Insmed (I......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Gilead Sciences (GILD) and ENDRA Life Sciences (NDRA......
Cantor Fitzgerald analyst Carter Gould maintained a Buy rating on Gilead Sciences on April 5 and set a price target of $155.00. According to TipRan......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Gilead Sciences (GILD) and ENDRA Life Sciences (NDRA......
Cantor Fitzgerald analyst Carter Gould maintained a Buy rating on Gilead Sciences on April 5 and set a price target of $155.00. According to TipRan......
Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences on April 3 and set a price target of $160.00. According to TipRanks, Br......
Anthropic, the artificial intelligence (AI) firm behind Claude, has just bought a small biotech startup called Coefficient Bio for about $400 milli......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Centene (CNC), Eli Lilly & Co (LLY) and Gilead Scien......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amgen (AMGN), Apogee Therapeutics (APGE) and Gilead Sciences (GIL......
Scotiabank analyst Louise Chen maintained a Buy rating on Gilead Sciences today and set a price target of $177.00. According to TipRanks, Chen is a......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 12 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GILD | $141.54 | 0% | 4.92M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |